Background Despite numerous interventions and treatment options, the outcomes of traumatic brain injury (TBI) have improved little over the last three decades, which raises concern about the value of care in this patient population. We aimed to synthesize the evidence on 14 potentially low-value clinical practices in TBI care.
Introduction
Traumatic brain injury (TBI) is the main cause of mortality from injury in people under 45 years of age [1] and leads to US$60 and €33 billion in medical costs in the USA [2] and Europe [3] each year. Moreover, outcomes following TBI have not improved significantly in the last four decades. [4, 5] Treatment options for TBI are multiple, but many lack robust evidence of their effectiveness. [6, 7] Low-value clinical practices, defined as 'a test or procedure that is not supported by evidence and/or could expose patients to unnecessary harm' [8] [9] [10] [11] [12] [13] [14] [15] consume up to 30% of healthcare resources. [16, 9] In the past decade, the medical community has turned towards the de-adoption of low-value practices as a promising means to reduce the strain on healthcare budgets, free-up resources and reduce harm to patients. [17] Physicians report using low-value practices because of a lack of alternative treatment options, fear of legal consequences, and a lack of guidelines on low-value care. [15, 18] The Brain Trauma Foundation, among others, publishes guidelines on TBI care. [19] However, emphasis is on practices that should be adhered to rather than practices that should be avoided.
Choosing Wisely publishes recommendations specifically targeting low-value practices, but few pertain to TBI care and many are based uniquely on expert consensus.[11] A previous scoping review and expert consultation survey identified 14 potentially low-value clinical practices in acute TBI care. [20] These practices represent potential targets for guidelines, overuse metrics and de-adoption interventions. However, before recommendations can be made, we need to synthesize the evidence base for these practices. The objective of the present study was to synthesize the evidence on potentially low-value intra-hospital clinical practices in acute TBI in adults.
Methods
Given the multitude of systematic reviews available for the clinical practices identified as potentially low-value, [20] we opted to conduct an umbrella review (a review of systematic reviews). [21] Our umbrella review was conducted according to published guidelines. [22] [23] [24] In the absence of reporting guidelines for umbrella reviews, we used applicable Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). [25] The protocol was published [26] and registered with the International Prospective Register of Systematic Reviews (PROSPERO: CRD42019132428). An ethics waiver was obtained from the CHU de Québec -Université Laval research ethics board.
Eligibility criteria
We considered systematic reviews of original studies evaluating the effectiveness of any of the 14 clinical practices previously identified in a scoping review and expert consultation study [20] in acute TBI in adults (exclusively ≥ 16 years old or less than 20% <16 years old). We limited the search to systematic reviews published in English since 1990, in line with umbrella review guidelines. [23, 24] The project steering committee comprising clinicians (two emergency physicians, seven critical care physicians, and one neurosurgeon), four methodologists, and three health system managers used the Population, Intervention, Comparator, Outcome and Study design (PICOS) framework to develop specific research questions for each of the 14 clinical practices (Additional file 1). [27, 20] We used the Cochrane definition to identify systematic reviews; we considered a review to be systematic if it clearly stated a set of objectives and reported explicit eligibility criteria, an extensive search strategy (a refined search strategy ran on MEDLINE or the Cochrane Library and at least one other database) [28, 29] and reproducible methods to identify, select, and critically appraise the findings of the included systematic reviews. [22] Outcomes Primary and secondary outcomes were identified for each of the 14 clinical practices by the project steering committee and are described in PICOS format in Additional file 1. The most common were intracranial injury for diagnostic interventions and the Glasgow Outcome Scale (GOS) or the GOS-Extended (GOS-E) for therapeutic interventions.
Search strategy
We developed comprehensive literature search strategies separately for each clinical practice on consultation with an information specialist (see Additional file 2 for PubMed search strategies). We searched systematic reviews using the Cochrane Library, Excerpta
Medica Database (EMBASE), Epistemonikos,[30] Medical Literature Analysis and Retrieval
System Online (MEDLINE) and the International Prospective Register of Systematic Reviews (PROSPERO)[31] from 1990 to up to six months prior to submission for publication. Using a snowball approach, we then screened the references of included studies in addition to previous reviews on this subject. [7, [32] [33] [34] [35] 
Selection process
We managed all citations with EndNote software (version X8.2, Clarivate Analytics, 2014).
We identified and removed duplicates using electronic and manual screening.
[36] To ensure reliability when selecting studies for a given practice, two sets of 100 citations were independently evaluated and then discussed by the reviewers. Pairs of reviewers (PAT, LM, IF) independently screened all identified records using titles, abstracts and full texts, consecutively. Any disagreement was resolved through discussion between reviewers and, if necessary, consultation with a senior author (AFT).
Data items and abstraction process
Using a standardized data abstraction form piloted on a representative sample of 5 systematic reviews, pairs of experienced reviewers (PAT, LM, IF) independently extracted the following data: first author, title, year of publication, databases used and date of the last search; population(s), intervention(s), comparator(s), outcome(s) and study designs included; measures of association and their respective measures of heterogeneity; risk of bias in original studies; and GRADE rating, when available. Any disagreement was resolved through discussion between reviewers and, if necessary, consultation with a senior author (AFT). When information was unclear or unavailable, we contacted systematic review authors with up to three email attempts.
Methodological quality assessment
Two reviewers (PAT, LM) independently critically appraised the quality of systematic reviews using the Assessing the Methodological Quality of Systematic Reviews (AMSTAR-2) tool. Methodological quality was categorised as critically low, low, moderate or high.
[37]
Synthesis
Results are presented according to current recommendations for umbrella reviews.
[38] For each low-value practice and each review, we present the number of studies according to their design, the sample size, the quality of the reviews (AMSTAR-2), measures of association for primary and secondary outcomes with their measures of heterogeneity, reported risk of bias for included studies, and reported strength of evidence (GRADE). [26] As GRADE was only used in 6/44 systematic reviews, we also evaluated evidence with credibility of evidence criteria used in previous umbrella reviews. [39, 40] These criteria class evidence from meta-analyses into four categories: convincing (class I), highly suggestive (class II), suggestive (class III), weak (class IV) and non-significant (NS), based on statistical significance, sample size, heterogeneity and risk of bias.
Results
Of 8,455 citations identified in the initial search, we assessed 212 full texts for eligibility ( Figure 1 ). Of these, 44 were deemed eligible and included in the synthesis (Additional file 3). Details of excluded systematic reviews are provided in Additional file 4.
Description of included reviews
At least one systematic review was identified for ten out of 14 targeted low-value practices ( Table 1 ). Systematic reviews conducted within the last five years were available for nine clinical practices and meta-analyses were available for eight practices. The number of systematic reviews varied from one for plasma transfusion and neuromuscular blocking agents to 19 for hypothermia. Reviews on imaging mostly defined primary outcomes as intracranial injury, neurological deterioration or neurosurgical intervention, and their population as patients with mild or mild complicated TBI. Systematic reviews on therapeutic interventions mainly focussed on the GOS or GOS-Extended, mortality, or adverse events in patients with moderate to severe TBI. Most systematic reviews restricted their population of interest to adults but some included pediatric patients. Nine systematic reviews did not specify targeted study designs in their PICOS. In 20 other systematic reviews, only RCTs were included and in 14 both randomized controlled trials and observational studies were considered.
Methodological quality of systematic reviews
Of the 44 included systematic reviews, two [41, 42] were rated high quality and eight[43-50] moderate quality (Additional file 5). All but two reviews [51, 52] [51, 52] used a comprehensive research strategy (95%), 17 (38%) established methods prior to the review and reported significant deviations from the study protocol, 34 (76%) used a satisfactory technique for reporting risk of bias, 20 (45%) accounted for risk of bias in individual studies when interpreting/discussing results, 33 out of the 34 reviews (97%) performing meta-analyses used appropriate analytic methods, and 20 (59%) investigated the presence of publication bias and discussed its potential impact on the results of metaanalyses.
Synthesis of results

Primary outcomes
Diagnostic interventions
We identified two reviews for CT in adults with mild TBI (both without meta-analyses), [44, 53] but only one presented data allowing us to calculate point estimates for our primary outcome;[44] less than 5% of patients who were classed as low-risk (any decision rule) had intracranial injury ( Table 2 ). Sample sizes were large for studies using the 
Therapeutic interventions
We identified two systematic reviews with meta-analyses on platelet transfusion in adults with TBI on antiplatelet therapy, which suggested increased risk of mortality in patients receiving the intervention, but estimates were imprecise and all CIs included the null value. [46, 55] The systematic review on antibiotic prophylaxis for basal skull fracture suggested that the intervention is associated with reduced odds of meningitis, but again the estimates were imprecise and covered the null value. [47] A systematic review by the same group reported no benefit of antibiotic prophylaxis for external ventricular drain placement in severe TBI in terms of risk of infection.
[41] We identified four systematic reviews with meta-analyses on seizure prophylaxis extended for more than one week after injury. [56, 57, 48, 58] Odds ratio (OR) and risks ratio (RR) varied from 0.40 to 1.28 across systematic reviews. The most widely studied drug, levetiracetam, was associated with a potential reduction in late seizures, but with confidence intervals (CI) covering the null value. Fifteen out of the nineteen systematic reviews identified for therapeutic hypothermia performed meta-analyses with the GOS as the primary outcome. [59] [60] [61] [62] [63] [64] 43, 65, 42, 66, 49, 67, 52, 68, 69] OR/RRs varied between 0.61 and 1.16 with 11 suggesting significant benefit (credibility of evidence 3 class II,[43,42,69] three class III [65, 67, 68] and 5 class IV[61-64,42]) and one [69] (the most recent) suggesting significant harm (class IV). In five meta-analyses on high-quality studies, OR/RR either covered the null value (n=3), [64, 65, 49] suggested significant harm (n=1) [69] or suggested significant benefit (n=1).
[42] Finally, we identified six systematic reviews on decompressive craniectomy, [70] [71] [72] [73] [74] [75] of which four presented quantitative synthesis on GOS. [70, 71, 74, 75] All were based exclusively on RCTs but were of low or critically low quality and had highly heterogeneous point estimates (I 2 ≥72%). Effect estimates were consistently close to one with CI covering the null value, suggesting no significant difference in outcome between intervention and control groups.
Secondary outcomes
Close to 0% of adults with mild TBI who were at low risk on a clinical decision rule for head CT required neurosurgical intervention (Additional file 6).
[44] Routine repeat head CT in mild complicated TBI without neurological deterioration led to a neurosurgical intervention in between 0.6 and 2.4% of patients, [76] [77] [78] a change in clinical management in between 0.6 [77] and 3.9% [78] and a change in intracranial pressure (ICP) monitoring in 1.2%. [78] Less than 0.2% of adults with mild TBI on anticoagulant or antiplatelet therapy with a routine repeat CT required neurosurgical treatment or died in hospital. [54] Authors of the single systematic review on antibiotic prophylaxis in adults with basal skull fractures reported no reduction in all-cause or meningitis-related mortality. [47] In, eight of the 15 systematic reviews on hypothermia, a statistically significant reduction in the risk or odds of mortality was observed whereas one review observed an increase. [61, 64, 43, 65, 67, 68, 50, 69] Five out of seven reviews that looked at pneumonia suggested higher risk/odds of this adverse event in adults receiving therapeutic hypothermia. [59, 64, 49, 67, 69] All of the four systematic reviews on decompressive craniectomy looked at mortality; [71, [73] [74] [75] three observed a statistically lower risk in the intervention group at 6 months. [73] [74] [75] Finally, two systematic reviews on decompressive craniectomy observed significantly lower mean intracranial pressure and shorter length of stay in the intervention group but significantly higher risk/odds of complications. [73, 75] 
Discussion
In this umbrella review on potentially low-value clinical practices in acute TBI care, the only clinical practices with any evidence of clinical benefit were routine repeat CT in mild complicated TBI (detection of progression of intracranial hemorrhage around 20%) and hypothermia (credibility of evidence II to IV). However, the most recent review for hypothermia based on high-quality trials suggested harm (credibility of evidence IV). [69] Meta-analyses on antibiotic prophylaxis in basal skull fractures all reported effect estimates consistent with clinically significant benefit but were statistically nonsignificant. [47] Meta-analyses on anti-platelet transfusion for adults with acute TBI on antiplatelet therapy all reported effect estimates consistent with clinically significant harm but were again statistically non-significant. [46, 55] For the following practices, effect estimates were consistently close to the null value suggesting no clinical benefit: CT in adults with mild TBI who are at low-risk on a validated clinical decision rule; [44] repeat CT in adults with mild TBI on anticoagulant or antiplatelet therapy with no clinical deterioration; [54] antibiotic prophylaxis for external ventricular drain placement;[41] and decompressive craniectomy for patients with refractory intracranial hypertension. [71, 68, 74, 75] However, confidence intervals were all wide.
Three clinical practices pertained to low-value imaging, which leads to increased costs, delays in care for other patients who require diagnostic imaging and is associated with an increased lifelong risk of cancer. [79] [80] [81] The review on CT in adults with mild TBI suggested less than 5% of patients who are at low-risk on a validated clinical decision rule had intracranial injury and less than 0.04% required neurosurgical intervention. Wisely). [82, 11] Less than 1% of adults with mild TBI on anticoagulant or antiplatelet therapy showed progression of hemorrhage on repeat CT or had poor outcomes. [54] However, the only systematic review on the subject was of very low quality. Evidence of low-value care for routinely repeating head CT in mild complicated TBI was less convincing with around one in five patients showing progression of hemorrhage. [76, 77, 83] This suggests the need to develop predictive models to more accurately identify patients at low risk of progression to avoid unnecessary repeat head CT scans in this population. It may also suggest that progression of intracranial hemorrhage is not the most clinically In terms of therapeutic interventions, evidence for platelet transfusion in adults on antiplatelet therapy suggested low-value care, with a non-significant increase in mortality in all systematic reviews.[46,55] Antiplatelet therapy was used in between 3% to 42% of these patients and given the adverse events associated with this practice, its de-adoption has the potential to improve patient outcomes in addition to freeing-up resources.
However, reviews were based on retrospective cohorts and evidence was graded as very low in all cases. A systematic review of moderate quality based on RCTs suggested a possible beneficial effect of antibiotic prophylaxis in adults with basal skull fractures with or without CSF leakage with evidence of moderate strength according to GRADE. [47] However, OR were imprecise with 95% CI covering the null value. The only review on antibiotic prophylaxis for external ventricular drain placement included one RCT which suggested no benefit in terms of infection incidence but this was based on a very imprecise pooled estimate and unclear risk of bias.
[41] Evidence on extended antiseizure prophylaxis was inconsistent; most point estimates suggested a protective effect, but all CI covered the null value. The review including the most RCTs (n=6; also with the highest methodological quality) observed a null effect and graded the evidence as very low regarding carbamazepine and phenytoin whereas the most recent review (critically low quality) observed a non-significant protective effect and graded evidence as high for levetiracetam and phenytoin. [48] For therapeutic hypothermia, multiple large RCTs have been conducted (the most comprehensive systematic review included 22 RCTs) [69] and targeted populations and interventions have changed over the years. The latest high-profile trials evaluated therapeutic hypothermia in all adults admitted to the ICU after a closed TBI with ICP>20 mm Hg for at least 5 minutes after stage I treatments (Eurotherm3235 Trial) [84] and prophylactic hypothermia in adults with severe TBI regardless of ICP prior to randomisation (POLAR-RCT). For decompressive craniectomy, point estimates for unfavorable outcome were close to the null value and statistically non-significant indicating no significant benefit of the intervention in terms of reduction in unfavorable outcome (GOS 1-4) at 6 months. Results are mostly driven by two large high-profile RCTs (DECRA [86] and RESCUE-ICP [87] ) that were both included in three of the four systematic reviews we identified. In the DECRA trial, decompressive craniectomy was conducted as a second-tier therapy; a statistically non-significant increase in unfavorable outcome at six months for the intervention group and no difference in mortality were observed. In the RESCUE-ICP trial, decompressive craniectomy was conducted as a third-tier therapy; the intervention group had significantly lower mortality at 6 months but no difference in unfavorable outcome was observed (gains in survival translated into more patients with severe disability). The systematic reviews we identified for this clinical practice had critical methodological flaws. Of note, Lu and colleagues [75] considered the GOS-E at 6 months for DECRA but at 12 months for RESCUE-ICP whereas Tsaousi [74] and Zhang [73] considered a GOS-E of three and less as an unfavorable outcome, therefore considering upper severe disability as favorable. This led to an overestimation of the benefit of the intervention in both cases.
Since the publication of DECRA and RESCUE-ICP, a consensus statement has been published recognizing the lack of evidence of effectiveness for improving patient outcome but recommending (based solely on consensus) decompressive craniotomy in specific situations, often dictated by physician gestalt and physician-family shared decisionmaking. [88] Limitations This review does have limitations which should be considered in the interpretation of results. First, to ensure the feasibility of the review, we restricted our search to the 14 low-value practices identified previously in a scoping review and expert consultation study, [20] which may have led us to miss some low-value practices. However, given the exhaustive search strategy used in the scoping review and the fact that experts were asked to add any other practices they considered low-value, it is unlikely that important low-value practices have been missed. Second, by targeting systematic reviews rather than original studies, we may have missed some evidence. For three clinical practices, we did not identify any systematic reviews, namely ICU admission in adults with acute mild complicated TBI who are not on direct oral anticoagulants, neurosurgical consultation in adults with acute mild TBI with normal head CT and albumin administration in severe TBI.
In addition, for plasma transfusion and neuromuscular blocking agents, all identified studies were qualitative. Furthermore, systematic reviews may not convey the most up-todate evidence or meet high quality standards. For example, at least one high-profile RCT has been published on hypothermia since the update of the most recent systematic review (POLAR trial) [85] and systematic reviews on decompressive craniectomy all had critical methodological flaws. [85] Fourth, meta-analysis results may not convey heterogeneity in effects, as indicated by the high heterogeneity of pooled estimates in many systematic reviews. For example, we may have missed differential effects of decompressive craniectomy as a second-tier or third-tier therapy or of therapeutic hypothermia according to timing and target temperature. Unfortunately, low numbers of studies precluded subgroup analyses for these factors. Fifth, all included reviews/studies aimed to demonstrate effectiveness (superiority trials) and were therefore not designed to formulate conclusions on low-value care (i.e. lack of effectiveness or harm). For this, inferiority trials would be necessary. Finally, for feasibility reasons, we limited this umbrella review to systematic reviews published in English since 1990 as per recommendations for umbrella reviews.[23,24] These limitations should have a negligible impact on results since no systematic reviews were published prior to 1990 (the first review identified was published in 2001) and most published reviews are written in English.[24,23] Among the 23 studies excluded based on language, only two were eligible based on the English abstract (published in Mandarin and Romanian) and their reported results (again from the abstract) were concordant with those of reviews included in our study.
Conclusion
We found low-grade evidence that the following clinical practices are either not beneficial or harmful: CT in adults with mild TBI who are at low-risk on a clinical decision rule; repeat CT for adults with mild TBI on anticoagulant or antiplatelet therapy prior to injury; platelet transfusions in adults on antiplatelet therapy; antibiotic prophylaxis for external ventricular drain placement; and decompressive craniectomy in patients with refractory intracranial hypertension. In addition, the most recent systematic review on high quality trials suggest that hypothermia is associated with harm when compared to normothermia.
We should now strive to measure the prevalence of these practices and assess inter- 
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